From & nbspEuronews
Was published
Advertising
From this Friday, only four specialties in Portugal will be able to prescribe glucose sensors and GLP-1 drugs, such as Semaglutidis, Doulaglutidis, Ligloutidis and Vellatidis. The special matters that leave this right are endocrinology and nutrition, internal pathology, pediatrics and general medicine.
Increase weight loss
Some of these drugs, such as Ovorpik From the Danish Novo Nordisk, although they are approved for type 2 diabetes, they are stunned for weight loss. This caused problems with accessibility in pharmacies.
Medicines and sensors in shortcomings
Other injection compositions, such as Maunjaro (Eli Lilly) and Wegovy (Novo nordisk) were approved for the treatment of both diabetes and obesity. According to the data, in the first four months of 2025, Portuguese consumers spent around 21 million euros To these drugs.
Diabetics without access
Even glucose sensors that are necessary for diabetics are exhausted in many cases, since they are increasingly used by people who do not have diabetes, such as athletes, influential people, diet or even animals, according to the newspaper PublicField
Formal intervention to protect patients
The Portuguese Ministry of Health in a decision published in April said that these abuses have seriously affected access to the needy. The corresponding ministerial decision was aimed at “correction of distortions” and ensure Correct and fair access In critical health tools.
Type of experts
President of the Portuguese Society of Diabetology, JawHe greeted the decision, but warned that this may not be enough to solve the problem. As he said in the agency LusaHe doubts whether the change will really contribute to access, since “the number of prescriptions from non -specialist doctors is not so large.”
Caring for unmistakable use
He indicated that diabetics and doctors do not oppose the use of these drugs for obesity, but emphasized that it exists Monitoring And an increase in “abnormal recipes.” He emphasized that “health should not be determined by market trends.”
High subsidies, black market and fake drugs
GLP-1 preparations are covered 90% of the Portuguese stateWhile glucose sensors before 85%The field, however, demand also led to Illegal trade From these preparations, creating dangers Fake medicines in the market.